HopeStage
Back to all studies
RecruitingNCT05647044

Safety and feasibility of iTBS for veterans with mild brain injury, impulsivity and suicidal thoughts

About this title

Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury

Read the official source — NCT05647044
Device studyAges 22–65United StatesSuicide prevention
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 65 years.

Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 20, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
55
Sponsor
VA Office of Research and Development
Sponsor type
Government agency
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 22 Years to 65 Years
Official registry ID
NCT05647044
Official title
Show the full official title

Neuromodulation for Impulsivity and Suicidality in Veterans With Mild Traumatic Brain Injury and Common Co-occurring Mental Health Conditions

Recruitment & locations

Currently recruiting

Hines

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VA Office of Research and Development, a government agency.

Who can participate?

Listed age limits: 22 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies